Rare diseases
Investigational molecules
Locations
Back to France458 clinical trials in Amiens, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceBI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases
FranceOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
FranceA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
FranceA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
FranceA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
FranceStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
FranceA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
FranceA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
FranceA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
FranceA study testing duvakitug for patients with moderately to severely active ulcerative colitis
FranceStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on head and neck cancers and multiple myeloma treatments. Studies include novel combination therapies and targeted approaches for improved patient outcomes.
Research emphasizes personalized treatment approaches combining immunotherapy with conventional treatments.
Comprehensive research into heart failure prevention and chronic kidney disease management, with focus on innovative therapeutic combinations.
Trials exploring new drug combinations and surgical interventions for improved cardiovascular outcomes.
Studies investigating treatments for Crohn's Disease and other inflammatory conditions, including innovative microbiota-based approaches.
Focus on developing targeted therapies and investigating treatment discontinuation strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
